![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication September 21, 2005.
Revised February 17, 2006.
Accepted for publication February 17, 2006.
:
Implications for Adenylyl Cyclase 2 Signaling
We have identified Dexras1 as a negative regulator of
protein kinase C (PKC)
and the consequences of
this regulation have been examined for adenylyl cyclase
(EC 4.6.1.1) type 2 (AC2) signaling. Dexras1 expression
in HEK293 cells completely abolished dopamine D2
receptor-mediated potentiation of AC2 activity, which is
consistent with previous reports of its ability to block
receptor-mediated G
signaling pathways.
Additionally, Dexras1 significantly reduced PMA-
stimulated AC2 activity but did not alter G
s-
mediated cyclic AMP accumulation. Dexras1 appeared to
inhibit PMA stimulation of AC2 by interfering with PKC&
[delta] autophosphorylation. This effect was selective
for the
isoform, as Dexras1 did not alter
autophosphorylation of PKC
or PKC
.
Dexras1 disruption of PKC
autophosphorylation
resulted in a significant blockade of its kinase
activity as measured by [32P]
-ATP incorporation
using a PKC-specific substrate. Moreover, Dexras1 and
PKC
co-immunoprecipitated from whole cell
lysates. Dexras1 did not alter the membrane
translocation of PKC
; however, the ability of
Dexras1 to interfere with PKC
autophosphorylation was isoprenylation-dependent as
determined using the farnesyltransferase inhibitor, FTI-
277, and a CAAX box-deficient Dexras1 (C277S) mutant.
PMA-stimulated AC2 activity was also not affected by
Dexras1C277S. Collectively, these data suggest that
Dexras1 functionally interacts with PKC
at the
cellular membrane through an isoprenylation-dependent
mechanism to negatively regulate PKC
activity.
Moreover our study suggests that Dexras1 acts to
modulate the activation of AC2 in an indirect fashion by
inhibiting both G
- and PKC-stimulated AC2
activity. The current study provides a novel role for
Dexras1 in signal transduction.
Key words:
Dopamine, Gi family, Adenylyl cyclases, Protein Kinase C, G protein regulation, Ras
This article has been cited by other articles:
![]() |
D. A. Dalmas, M. S. Scicchitano, Y. Chen, J. Kane, R. Mirabile, L. W. Schwartz, H. C. Thomas, and R. W. Boyce Transcriptional Profiling of Laser Capture Microdissected Rat Arterial Elements: Fenoldopam-induced Vascular Toxicity as a Model System Toxicol Pathol, April 1, 2008; 36(3): 496 - 519. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Newton and N. S. Holden Separating Transrepression and Transactivation: A Distressing Divorce for the Glucocorticoid Receptor? Mol. Pharmacol., October 1, 2007; 72(4): 799 - 809. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lindsey Dexamethasone-induced Ras-related protein 1 is a potential regulatory protein in B lymphocytes Int. Immunol., May 1, 2007; 19(5): 583 - 590. [Abstract] [Full Text] [PDF] |
||||